Titan Pharmaceuticals Inc.
- UEI
- E6BMASC5QBS9
- CAGE
- 47F74
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Website
- titanpharm.com
- Founded
- 1992
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract vehicles
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Endo Usa, Inc. | Malvern, PA | 325412 Pharmaceutical Preparation Manufacturing |
| U.s. Division | Rockville, MD | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
| TG Therapeutics Inc. | Morrisville, NC | 325412 Pharmaceutical Preparation Manufacturing |
| Fennec Pharmaceuticals, Inc. | Durham, NC | 325412 Pharmaceutical Preparation Manufacturing |
| Summit SD LLC | Lee's Summit, MO | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
About the company
Titan Pharmaceuticals Inc. is a development stage biotechnology company that develops proprietary therapeutics for the treatment of serious medical disorders. As a corporate entity registered in SAM.gov, Titan Pharmaceuticals Inc. has received federal contracts to provide pharmaceuticals and drugs to government agencies.
Titan Pharmaceuticals Inc. has not received any prime federal grants, but has received several federal sub-grant awards from Oregon Health & Science University to support the development of an implantable device for long-term protection against malaria. As a sub-awardee on these federal grants, Titan Pharmaceuticals Inc. provides research and development services related to the malaria prevention device.
Titan Pharmaceuticals Inc. holds two federal supply schedule indefinite delivery indefinite quantity (IDIQ) contracts with the Department of Veterans Affairs to provide drugs, pharmaceuticals, and hematology-related products under the Pharmaceuticals and Drugs schedule. The most recent IDIQ has a potential value of $225,000 and runs through January 2025, allowing the VA to procure needed pharmaceuticals from Titan Pharmaceuticals Inc. to support treatment of veterans. The company also held a short-term IDIQ to provide similar pharmaceutical products, which expired in February 2020. As a multiple award IDIQ contract vehicle, these contracts are open for orders from various VA medical centers and outpatient clinics in Veterans Integrated Service Network 12.
Quick answers
Is Titan Pharmaceuticals Inc. registered in SAM.gov?
Titan Pharmaceuticals Inc.'s SAM.gov registration expired on August 21, 2024.
Which contract vehicles does Titan Pharmaceuticals Inc. hold?
Titan Pharmaceuticals Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Titan Pharmaceuticals Inc.'s most recent federal award?
Titan Pharmaceuticals Inc.'s most recent federal grant award is Nalmefene implant for the long-term treatment of opioid use disorder (UG3DA047707), from National Institute on Drug Abuse (NIH), on September 15, 2018.
On GovTribe
See Titan Pharmaceuticals Inc.'s full federal record
- IDV awards
- Contract vehicles
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors